The FDA approved Eli Lilly's Foundayo (orforglipron) on April 1 the first oral GLP-1 pill for weight loss that can be taken at any time of day, with no fasting, food, or water restrictions
Our analysis also revealed important findings regarding dry eye disease and other ocular outcomes that merit specific attention
If you are monitoring your blood glucose, do not be surprised if your numbers look higher than usual while you have the flu
There are several mechanisms by which glucagon prevents hypoglycemia, such as induction of hepatic gluconeogenesis and glycogenolysis, and the inhibition of hepatic glycogenesis
Materials and methods Study design The study design was outlined in Fig
Qin M, Chen W, Hua L, et al